Sharp Edge Labs
Latest round
- Series C
Last raised
- Jun 2017
Total raised
- $0.7M
Investors
- 2
About Sharp Edge Labs
Based in Pennsylvania, US, and founded in 2010, Sharp Edge Labs, Inc. operates as a biotechnology company that develops biosensors for patients with protein trafficking disorders. In August 2019, Sharp Edge Labs Inc. Sneddon, co-founder and CTO, Marcel Bruchez, and co-founder and chief architect, Alan Waggoner. The company is dedicated to transforming the lives of patients with genetic diseases. Sharp develops small molecule drugs that restore the function of mutated proteins, to correct the fundamental imbalances caused by genetic mutations, turning diagnoses into hope for affected individuals. Sharp has focused on leveraging its unique suite of technologies—CoreX™, AlloChem™, and Disco™/Mine™. CoreX™ employs biology techniques to create sensitive assays that mimic disease states, facilitating the discovery of compounds that can correct mutational defects. AlloChem™ utilizes computational methods to design compound libraries enriched with drug-like correctors, which are then tested experimentally. Disco™/Mine™ integrates big data analytics and AI to enhance drug discovery, enabling the identification of effective treatments where traditional methods fall short.
Who invested in Sharp Edge Labs
2 investors across 3 rounds
See all investors in Sharp Edge Labs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sharp Edge Labs
Who invested in Sharp Edge Labs?
Sharp Edge Labs has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sharp Edge Labs raised?
Sharp Edge Labs has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Sharp Edge Labs last raise money?
Sharp Edge Labs's most recent round on record is a Series C, in Jun 2017.
What does Sharp Edge Labs do?
Based in Pennsylvania, US, and founded in 2010, Sharp Edge Labs, Inc.
Where is Sharp Edge Labs headquartered?
Sharp Edge Labs is headquartered in Pittsburgh, US.
Which VCs invest in companies like Sharp Edge Labs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sharp Edge Labs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Sharp Edge Labs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.